Loomis, Sayles & Company
EPZM

Loomis, Sayles & Company’s Epizyme, Inc EPZM Stock Holding History

Loomis, Sayles & Company’s Portfolio EPZM Stock Details EPZM Fund Activity
Upgrade to unlock
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		– Sell
2020
Q2 		$22.3M Buy
2020
Q1 		$19.6M Sell
2019
Q4 		$39.4M Sell
2019
Q3 		$16.6M Buy